Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liberg

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Dermatological Science|May 10, 2016
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosisMartin Stenström, Helén Carlsson Nyhlén, Marie Törngren, et al.
Plos Biology|May 1, 2009
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamidesPer Björk, Anders Björk, Thomas Vogl, et al.
Plos One|December 15, 2015
Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid CellsParamita Chakraborty, Per Bjork, Eva Källberg, et al.
Plos One|April 4, 2012
S100A9 interaction with TLR4 promotes tumor growthEva Källberg, Thomas Vogl, David Liberg, et al.
Plos One|May 14, 2013
Common interactions between S100A4 and S100A9 defined by a novel chemical probePer Björk, Eva Källberg, Ulf Wellmar, et al.
Cancer Discovery|April 27, 2025
HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Cancer Discovery|March 2, 2026
Correction: HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Journal of the American Heart Association|May 15, 2025
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and AdhesionMadelene Lindkvist, Anna Göthlin Eremo, Geena Varghese Paramel, et al.
Physiological Genomics|August 18, 2005
Gene expression analysis suggests that EBF-1 and PPARgamma2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kineticsPeter Akerblad, Robert Månsson, Anna Lagergren, et al.
Journal for Immunotherapy of Cancer|December 18, 2015
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironmentAnders Olsson, Jessica Nakhlé, Anette Sundstedt, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Dermatological Science|May 10, 2016
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosisMartin Stenström, Helén Carlsson Nyhlén, Marie Törngren, et al.
Plos Biology|May 1, 2009
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamidesPer Björk, Anders Björk, Thomas Vogl, et al.
Plos One|December 15, 2015
Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid CellsParamita Chakraborty, Per Bjork, Eva Källberg, et al.
Plos One|April 4, 2012
S100A9 interaction with TLR4 promotes tumor growthEva Källberg, Thomas Vogl, David Liberg, et al.
Plos One|May 14, 2013
Common interactions between S100A4 and S100A9 defined by a novel chemical probePer Björk, Eva Källberg, Ulf Wellmar, et al.
Cancer Discovery|April 27, 2025
HPV16-Expressing Tumors Release Multiple IL-1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Cancer Discovery|March 2, 2026
Correction: HPV16-Expressing Tumors Release Multiple IL1 Ligands to Orchestrate Systemic Immunosuppression Whose Disruption Enables Efficacy of a Therapeutic VaccineMorgane Lecointre, Jérémy Guillot, Rachel Marcone, et al.
Journal of the American Heart Association|May 15, 2025
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and AdhesionMadelene Lindkvist, Anna Göthlin Eremo, Geena Varghese Paramel, et al.
Physiological Genomics|August 18, 2005
Gene expression analysis suggests that EBF-1 and PPARgamma2 induce adipogenesis of NIH-3T3 cells with similar efficiency and kineticsPeter Akerblad, Robert Månsson, Anna Lagergren, et al.
Journal for Immunotherapy of Cancer|December 18, 2015
Tasquinimod triggers an early change in the polarization of tumor associated macrophages in the tumor microenvironmentAnders Olsson, Jessica Nakhlé, Anette Sundstedt, et al.
Pageof 3